Innate immune response may predict COVID-19 severity

Innate immune response may predict COVID-19 severity

Innate immune response may predict COVID-19 severity
Figure 1. Disease severity-dependent neutrophilia and marked decrease of eosinophils and basophils in COVID-19. (A) Experimental and analytical workflow of the study performed on samples from moderate and severe COVID-19 patients and age-matched healthy controls. (B) Dot plots (Left) and alluvial diagram (Right) describing demographics and the clinical characteristics of the patients included in the study cohort. Individual patient values are reported in SI Appendix, Fig. S1A. Severity groups (moderate, blue; severe, purple; deceased, gray) are indicated. Oxygen scale: 1, no oxygen supply; 2, oxygen

COVID-19 disease severity seems to be affected by the characteristics of white blood cells called granulocytes, which are part of the innate immune system. Combined measurements of granulocytes and well-known biomarkers in the blood can predict the severity of the disease, according to a new study from Karolinska Institutet. The results are published in the journal PNAS and may eventually contribute to more tailored treatments for COVID-19 patients.

Granulocytes are a family of white blood cells that include neutrophils, eosinophils and basophils. They are part of the so-called innate immune system, which is the body’s first line of defense against pathogens. There are many studies on how SARS-CoV-2 affects various components of the immune system, but there is still a lack of knowledge about the role of granulocytes in COVID-19.

Researchers at Karolinska Institutet have now investigated the characteristics of granulocytes in the blood during the early phase of SARS-CoV-2 infection in a total of 26 hospitalized patients with COVID-19 at the Karolinska University Hospital. They also performed follow-up analyses four months after hospital discharge and compared these with analyses of healthy uninfected individuals.

Significantly altered characteristics

“Our study shows significantly altered characteristics of all granulocyte subsets in COVID-19 patients and this can be linked to the severity of the disease,” says lead author Magda Lourda, who is a researcher at the Department of Medicine, Huddinge, at Karolinska Institutet.

Combined measurements of granulocyte characteristics and widely used biomarkers in the blood called C-reactive protein (CRP) and creatinine, could predict key clinical features such as respiratory function and multiorgan failure.

“The finding needs to be taken with caution considering the limited size of our study cohort, but our hope is that these combined measurements can be used to predict the severity of the disease, resulting in more tailored treatments for COVID-19 patients,” says Magda Lourda.

Granulocytes may weaken immune response in connection with COVID-19

More information:
Magda Lourda et al, High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19, Proceedings of the National Academy of Sciences (2021). DOI: 10.1073/pnas.2109123118

Innate immune response may predict COVID-19 severity (2021, September 23)
retrieved 24 September 2021

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.